{"id":54738,"date":"2022-07-22T08:05:43","date_gmt":"2022-07-22T13:05:43","guid":{"rendered":"https:\/\/www.partnershipagainstcancer.ca\/?post_type=corporate-documents&#038;p=54738"},"modified":"2026-10-01T10:16:04","modified_gmt":"2026-10-01T15:16:04","slug":"remuneration","status":"publish","type":"corporate-documents","link":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/","title":{"rendered":"R\u00e9mun\u00e9ration"},"content":{"rendered":"\r\n<p class=\"wp-block-paragraph\"><strong>1.<\/strong> Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e au personnel permanent \u00e0 temps plein s\u2019\u00e9levaient \u00e0 18\u00a0968\u00a0234\u00a0$ pour l\u2019ann\u00e9e civile close le\u00a031\u00a0d\u00e9cembre\u00a02025.<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\"><strong>2.<\/strong> Le nombre total de membres du personnel permanents \u00e0 temps plein au 31\u00a0mars\u00a02026 \u00e9tait de 130. \u00c0 l\u2019occasion, le Partenariat fait appel \u00e0 du personnel contractuel pour g\u00e9rer la charge de travail.<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\"><strong>3. <\/strong> Montant total de la r\u00e9mun\u00e9ration vers\u00e9e aux membres du personnel suivants pour l\u2019ann\u00e9e civile close le 31\u00a0d\u00e9cembre\u00a02025 (tel que d\u00e9clar\u00e9 sur les feuillets\u00a0T4 pour 2025) :<\/p>\r\n<table class=\"table table-bordered\">\r\n<tbody>\r\n<tr class=\"active\">\r\n<th style=\"vertical-align: top;\" width=\"33%\"><strong>Titre <\/strong><\/th>\r\n<th style=\"vertical-align: top;\" width=\"33%\"><strong>R\u00e9mun\u00e9ration (feuillets T4 pour 2025)<\/strong><\/th>\r\n<th style=\"vertical-align: top;\" width=\"33%\"><strong>Avantages imposables (inclus dans le montant de la r\u00e9mun\u00e9ration)<\/strong><\/th>\r\n<\/tr>\r\n<\/tbody>\r\n<tbody>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"302\">Pr\u00e9sident-directeur g\u00e9n\u00e9ral<\/td>\r\n<td style=\"vertical-align: top;\" width=\"124\">784\u00a0688,71 $<\/td>\r\n<td style=\"vertical-align: top;\" width=\"160\">4\u00a0404,48 $<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"302\">Vice-pr\u00e9sidente, Finances et services de l\u2019entreprise<\/td>\r\n<td style=\"vertical-align: top;\" width=\"124\">303\u00a0404,79 $<\/td>\r\n<td style=\"vertical-align: top;\" width=\"160\">4\u00a0800,83 $<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"302\">Vice-pr\u00e9sidente, Partenariats strat\u00e9giques<\/td>\r\n<td style=\"vertical-align: top;\" width=\"124\">319\u00a0411,10 $<\/td>\r\n<td style=\"vertical-align: top;\" width=\"160\">4\u00a0800,83 $<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"302\">Vice-pr\u00e9sidente, Syst\u00e8mes de lutte contre le cancer et innovation*<\/td>\r\n<td style=\"vertical-align: top;\" width=\"124\">263\u00a0266,06 $<\/td>\r\n<td style=\"vertical-align: top;\" width=\"160\">3\u00a0794,73 $<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"302\">Vice-pr\u00e9sidente par int\u00e9rim, Syst\u00e8mes de lutte contre le cancer et innovation**<\/td>\r\n<td style=\"vertical-align: top;\" width=\"124\">222\u00a0420,64 $<\/td>\r\n<td style=\"vertical-align: top;\" width=\"160\">3\u00a0404,08 $<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n\r\n<p><em><small>* En cong\u00e9 pendant une partie de 2025 (la r\u00e9mun\u00e9ration indiqu\u00e9e comprend les droits de cong\u00e9)<br \/>**\u00a0Poste de vice-pr\u00e9sidente par int\u00e9rim pour le remplacement de la titulaire durant son cong\u00e9 (comprend le salaire de directrice vers\u00e9 \u00e0 la personne ayant assur\u00e9 l\u2019int\u00e9rim pendant une partie de 2025)<\/small><\/em>\u00a0<\/p>\r\n<p><strong>4.<\/strong> Fourchettes salariales du personnel du Partenariat (en vigueur au 31 mars 2026) :<\/p>\r\n<table class=\"table table-bordered\">\r\n<tbody>\r\n<tr class=\"active\">\r\n<th style=\"vertical-align: top;\" width=\"10%\"><strong>Niveau<\/strong><\/th>\r\n<th style=\"vertical-align: top;\" width=\"40%\"><strong>Poste<\/strong><\/th>\r\n<th style=\"vertical-align: top;\" width=\"40%\"><strong>Fourchette de r\u00e9mun\u00e9ration annuelle<\/strong><\/th>\r\n<th style=\"vertical-align: top;\" width=\"10%\">Nombre de membres du personnel permanent \u00e0 temps plein<\/th>\r\n<\/tr>\r\n<\/tbody>\r\n<tbody>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"60\">9<\/td>\r\n<td style=\"vertical-align: top;\" width=\"264\">Directeur(-trice)<\/td>\r\n<td style=\"vertical-align: top;\" width=\"144\">131\u00a0895\u00a0$ \u2013 202\u00a0753\u00a0$<\/td>\r\n<td style=\"vertical-align: top;\" width=\"118\">11<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"60\">8<\/td>\r\n<td style=\"vertical-align: top;\" width=\"264\">Contr\u00f4leur(-euse) de gestion, architecte d\u2019entreprise<\/td>\r\n<td style=\"vertical-align: top;\" width=\"144\">120\u00a0936\u00a0$ \u2013 166\u00a0466\u00a0$<\/td>\r\n<td style=\"vertical-align: top;\" width=\"118\">2<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"60\">7<\/td>\r\n<td style=\"vertical-align: top;\" width=\"264\">Gestionnaire, partenaire principal d\u2019affaires en RH, gestionnaire de programme, responsable<\/td>\r\n<td style=\"vertical-align: top;\" width=\"144\">100\u00a0780\u00a0$ \u2013 138\u00a0721 $<\/td>\r\n<td style=\"vertical-align: top;\" width=\"118\">29<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"60\">6<\/td>\r\n<td style=\"vertical-align: top;\" width=\"264\">Analyste, gestionnaire de programme, gestionnaire de service, responsable, sp\u00e9cialiste, conseiller(-\u00e8re), comptable principal(e), d\u00e9veloppeur(-euse) Web, gestionnaire de projet<\/td>\r\n<td style=\"vertical-align: top;\" width=\"144\">80\u00a0624\u00a0$ \u2013 109\u00a0080\u00a0$<\/td>\r\n<td style=\"vertical-align: top;\" width=\"118\">56<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"60\">5<\/td>\r\n<td style=\"vertical-align: top;\" width=\"264\">Analyste, agent(e), adjointe de direction au pr\u00e9sident-directeur g\u00e9n\u00e9ral, adjointe de direction \u00e0 la vice-pr\u00e9sidente, Finances et services de l\u2019entreprise\/agente de liaison avec le conseil, adjointe de direction \u00e0 la vice-pr\u00e9sidente, Syst\u00e8mes de lutte contre le cancer et innovation et \u00e0 la vice-pr\u00e9sidente, Partenariats strat\u00e9giques<\/td>\r\n<td style=\"vertical-align: top;\" width=\"144\">70\u00a0723\u00a0$ \u2013 95\u00a0683\u00a0$<\/td>\r\n<td style=\"vertical-align: top;\" width=\"118\">14<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"60\">4<\/td>\r\n<td style=\"vertical-align: top;\" width=\"264\">Coordonnateur(-trice)<\/td>\r\n<td style=\"vertical-align: top;\" width=\"144\">54\u00a0419\u00a0$ \u2013 73\u00a0626\u00a0$<\/td>\r\n<td style=\"vertical-align: top;\" width=\"118\">10<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"60\">3<\/td>\r\n<td style=\"vertical-align: top;\" width=\"264\">Adjoint(e) administratif(-ive)<\/td>\r\n<td style=\"vertical-align: top;\" width=\"144\">47\u00a0736\u00a0$ \u2013 64\u00a0584\u00a0$<\/td>\r\n<td style=\"vertical-align: top;\" width=\"118\">4<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"60\"><strong>\u00a0<\/strong><\/td>\r\n<td style=\"vertical-align: top;\" width=\"264\">\u00a0<\/td>\r\n<td style=\"vertical-align: top;\" width=\"144\"><strong>T<\/strong><strong>OTAL<\/strong><\/td>\r\n<td style=\"vertical-align: top;\" width=\"118\"><strong>130*<\/strong><\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<p><em><small>*\u00a0Comprend 126\u00a0employ\u00e9es et employ\u00e9s et 4\u00a0membres de la haute direction<\/small><\/em><\/p>\r\n<p><strong>5.<\/strong> Le montant total de la r\u00e9mun\u00e9ration vers\u00e9e aux membres du conseil d\u2019administration du Partenariat pour l\u2019exercice clos le\u00a031\u00a0d\u00e9cembre\u00a02025 (tel que d\u00e9clar\u00e9 \u00e0 l\u2019Agence du revenu du Canada sur les feuillets\u00a0T4 pour 2025) s\u2019\u00e9levait \u00e0 107\u00a0000\u00a0$.<\/p>\r\n<h3>R\u00e9mun\u00e9ration du Partenariat<\/h3>\r\n<ul>\r\n<li><a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2024-2025\/\">R\u00e9mun\u00e9ration 2024-2025<\/a><\/li>\r\n<li><a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2022-2023\/\">R\u00e9mun\u00e9ration 2022-2023<\/a><\/li>\r\n<li><a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2021-2022\/\">R\u00e9mun\u00e9ration 2021-2022<\/a><\/li>\r\n<li><a href=\"https:\/\/s22457.pcdn.co\/wp-content\/uploads\/2021\/07\/Salary_Disclosure_2020-2021_FR.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9mun\u00e9ration 2020-2021<\/a><\/li>\r\n<li><a href=\"https:\/\/s22457.pcdn.co\/wp-content\/uploads\/2020\/08\/Compensation-FR.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9mun\u00e9ration 2019-2020<\/a><\/li>\r\n<li><a href=\"https:\/\/s22457.pcdn.co\/wp-content\/uploads\/2019\/07\/Disclosure_Document_FR.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9mun\u00e9ration 2018-2019<\/a><\/li>\r\n<li><a href=\"https:\/\/s22457.pcdn.co\/wp-content\/uploads\/2018\/08\/Salaries-and-Disclosure_Fre_Final.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9mun\u00e9ration 2017-2018<\/a><\/li>\r\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>1. Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e au personnel permanent \u00e0 temps plein s\u2019\u00e9levaient \u00e0 18\u00a0968\u00a0234\u00a0$ pour l\u2019ann\u00e9e civile close le\u00a031\u00a0d\u00e9cembre\u00a02025. 2. Le nombre total de membres du personnel permanents \u00e0 temps plein au 31\u00a0mars\u00a02026 \u00e9tait de 130. \u00c0 l\u2019occasion, le Partenariat fait appel \u00e0 du personnel contractuel pour g\u00e9rer la charge [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":0,"menu_order":0,"template":"","corporate_documents_categories":[1033],"class_list":["post-54738","corporate-documents","type-corporate-documents","status-publish","hentry","corporate_documents_categories-performance-accountability"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Canadian Partnership Against Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer\" \/>\n<meta property=\"og:description\" content=\"1. Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e au personnel permanent \u00e0 temps plein s\u2019\u00e9levaient \u00e0 18\u00a0968\u00a0234\u00a0$ pour l\u2019ann\u00e9e civile close le\u00a031\u00a0d\u00e9cembre\u00a02025. 2. Le nombre total de membres du personnel permanents \u00e0 temps plein au 31\u00a0mars\u00a02026 \u00e9tait de 130. \u00c0 l\u2019occasion, le Partenariat fait appel \u00e0 du personnel contractuel pour g\u00e9rer la charge [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Partnership Against Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-01T15:16:04+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cancerstratca\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/about-us\\\/corporate-strategic-document\\\/remuneration\\\/\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/about-us\\\/corporate-strategic-document\\\/remuneration\\\/\",\"name\":\"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\"},\"datePublished\":\"2022-07-22T13:05:43+00:00\",\"dateModified\":\"2026-10-01T15:16:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/about-us\\\/corporate-strategic-document\\\/remuneration\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/about-us\\\/corporate-strategic-document\\\/remuneration\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/about-us\\\/corporate-strategic-document\\\/remuneration\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Corporate Documents\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/about-us\\\/corporate-strategic-document\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"R\u00e9mun\u00e9ration\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\",\"url\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/\",\"name\":\"Canadian Partnership Against Cancer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Partnership Against Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/","og_locale":"fr_FR","og_type":"article","og_title":"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer","og_description":"1. Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e au personnel permanent \u00e0 temps plein s\u2019\u00e9levaient \u00e0 18\u00a0968\u00a0234\u00a0$ pour l\u2019ann\u00e9e civile close le\u00a031\u00a0d\u00e9cembre\u00a02025. 2. Le nombre total de membres du personnel permanents \u00e0 temps plein au 31\u00a0mars\u00a02026 \u00e9tait de 130. \u00c0 l\u2019occasion, le Partenariat fait appel \u00e0 du personnel contractuel pour g\u00e9rer la charge [&hellip;]","og_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/","og_site_name":"Canadian Partnership Against Cancer","article_publisher":"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/","article_modified_time":"2026-10-01T15:16:04+00:00","twitter_card":"summary_large_image","twitter_site":"@cancerstratca","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/","url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/","name":"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer","isPartOf":{"@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website"},"datePublished":"2022-07-22T13:05:43+00:00","dateModified":"2026-10-01T15:16:04+00:00","breadcrumb":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Corporate Documents","item":"https:\/\/www.partnershipagainstcancer.ca\/about-us\/corporate-strategic-document\/"},{"@type":"ListItem","position":2,"name":"R\u00e9mun\u00e9ration"}]},{"@type":"WebSite","@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website","url":"https:\/\/dev.partnershipagainstcancer.ca\/","name":"Canadian Partnership Against Cancer","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.partnershipagainstcancer.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/corporate-documents\/54738","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/corporate-documents"}],"about":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/types\/corporate-documents"}],"author":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/users\/24"}],"wp:attachment":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=54738"}],"wp:term":[{"taxonomy":"corporate_documents_categories","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/corporate_documents_categories?post=54738"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}